Literature DB >> 3643771

Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.

J K Foster, J R Lentino, R Strodtman, C DiVincenzo.   

Abstract

Quinolone antibiotics have been proposed as possible alternatives to vancomycin for methicillin-resistant Staphylococcus aureus infections. We investigated the activities of amifloxacin, ciprofloxacin, norfloxacin, and vancomycin by time-kill kinetic studies. Antibiotic concentrations of 0, 1.0, and 4.0 times the MIC were used against four strains of gentamicin- and methicillin-resistant S. aureus. Staphylococci were plated onto ciprofloxacin-containing agar at all time points, in repeat time-kill kinetic studies. Macrobroth dilution MICs and MBCs were determined. Ciprofloxacin levels were measured by bioassay. Replica plating was performed from the original susceptible inoculum (MIC, 0.125 micrograms/ml) onto ciprofloxacin-supplemented agar. At 4.0 times the MIC, only with ciprofloxacin was there regrowth at 24 and 48 h. All four strains of staphylococci grew on agar supplemented with 1 microgram of ciprofloxacin per ml; three of four grew on agar supplemented with 2 micrograms of ciprofloxacin per ml. MICs and MBCs for these resistant clones ranged from 8 to 32 micrograms/ml. No degradation in activity or amount of ciprofloxacin could be detected in the bioassay. Replica-plated staphylococci grew on agar containing 1 microgram/ml but not higher concentrations of ciprofloxacin at 48 h. Amifloxacin and norfloxacin sustained bactericidal activity comparable to that of vancomycin. We conclude that heteroresistant subpopulations of gentamicin- and methicillin-resistant S. aureus can emerge under antibiotic selection pressure. Such resistant clones may then mutate in the presence of subinhibitory concentrations of antibiotic to higher levels of ciprofloxacin resistance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3643771      PMCID: PMC180601          DOI: 10.1128/AAC.30.6.823

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Antimicrobial spectrum of Win 49375.

Authors:  N V Jacobus; F P Tally; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

2.  New recommendations for disk diffusion antimicrobial susceptibility tests for methicillin-resistant (heteroresistant) staphylococci.

Authors:  L K McDougal; C Thornsberry
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

3.  Reliability of the microdilution technic for detection of methicillin-resistant strains of staphylococcus aureus.

Authors:  A L Barry; R E Badal
Journal:  Am J Clin Pathol       Date:  1977-05       Impact factor: 2.493

4.  Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center.

Authors:  D P Levine; R D Cushing; J Jui; W J Brown
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

5.  Vancomycin therapy for methicillin-resistant Staphylococcus aureus.

Authors:  T C Sorrell; D R Packham; S Shanker; M Foldes; R Munro
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

6.  Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks.

Authors:  L D Saravolatz; D J Pohlod; L M Arking
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

7.  Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  R L Thompson; I Cabezudo; R P Wenzel
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

8.  In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.

Authors:  G M Eliopoulos; A Gardella; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

9.  Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus.

Authors:  L D Sabath
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

10.  Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors.

Authors:  P C Taylor; F D Schoenknecht; J C Sherris; E C Linner
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

View more
  12 in total

1.  Constant rate infusion of vancomycin in premature neonates: a new dosage schedule.

Authors:  F Pawlotsky; A Thomas; M F Kergueris; T Debillon; J C Roze
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

2.  Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.

Authors:  C W Stratton; C Liu; L S Weeks
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

Review 3.  Diagnosis and management of methicillin resistant Staphylococcus aureus infection.

Authors:  G J Duckworth
Journal:  BMJ       Date:  1993-10-23

4.  Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital.

Authors:  I Shalit; S A Berger; A Gorea; H Frimerman
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

Review 5.  New antimicrobial agents as therapy for resistant gram-positive cocci.

Authors:  J R Lentino; M Narita; V L Yu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01       Impact factor: 3.267

6.  Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation.

Authors:  Cornelia B Landersdorfer; Martina Kinzig; Friedrich F Hennig; Jürgen B Bulitta; Ulrike Holzgrabe; George L Drusano; Fritz Sörgel; Johannes Gusinde
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

7.  Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.

Authors:  P A Maple; J M Hamilton-Miller; W Brumfitt
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

Review 8.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

9.  TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus.

Authors:  H Hanaki; H Akagi; Y Masaru; T Otani; A Hyodo; K Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

10.  Identification of simple arylfluorosulfates as potent agents against resistant bacteria.

Authors:  Jiong Zhang; Xiangxiang Zhao; John R Cappiello; Yi Yang; Yunfei Cheng; Guang Liu; Wenjing Fang; Yinzhu Luo; Yu Zhang; Jiajia Dong; Lixin Zhang; K Barry Sharpless
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.